Multi-institutional phase II, randomized dose finding study of defibrotide (DF) in patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Promising response rate without significant toxicity in a high risk population.
Richardson, PG; Warren, DL; Momtaz, P; Soiffer, R; Antin, JH; Spitzer, T; Avigan, D; Wei, LJ; Jin, Z; Rifai, N; Bradwin, G; Vredenburgh, J; Kurtzberg, J; Martin, PL; Vogelsang, G; Arai, S; Chen, A; McDonald, GB; Murray, K; Iacobelli, M; Guinan, EC
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)